↑ arvau

Wikipedia / Patrick Cramer

Patrick Cramer (born 3 February 1969) is a German chemist, structural biologist, and molecular systems biologist. In 2020, he was elected an international member of the National Academy of Sciences. He became president of the Max Planck Society in June 2023.

Early life and education

Cramer studied chemistry at the University of Stuttgart and Heidelberg University (Germany) from 1989 until 1995. He completed a part of his studies as ERASMUS scholar at the University of Bristol in the UK. As a research student, he also worked in the lab of Sir Alan Fersht in Cambridge, UK at the MRC Laboratory for Molecular Biology (LMB) site. In 1995 until 1998 he worked as a PhD student in laboratory of Christoph W. Müller at the European Molecular Biology Laboratory (EMBL) in Grenoble, France. He obtained his PhD in natural sciences (Dr. rer. nat.) from Heidelberg University in 1998.

Career in research

Stanford University, 1999–2001

From 1999 until 2001 Cramer worked as postdoctoral researcher and fellow of the German Research Foundation (DFG) in the laboratory of the later Nobel Prize laureate Roger D. Kornberg at Stanford University, USA.

LMU Munich, 2001–2013

In 2001, Cramer returned to Germany, where he obtained a tenure-track professorship for biochemistry at the Gene Center of LMU Munich where he was later, in 2004, appointed full professor of biochemistry. Patrick Cramer headed the LMU Gene Center for 10 years, from 2004 until 2013. He also served as Dean of the School of Chemistry and Pharmacy from 2007 to 2009, and as Director of the Department of Biochemistry from 2010 to 2013. Cramer also was a member of the University Research Board from 2007 to 2013 and speaker of the research network grant SFB464 of the German Research Council (DFG).

Max Planck Institute for Biophysical Chemistry, 2014–2023

In 2014, Cramer was appointed Director at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany.

Max Planck Society, 2023–present

Since 22 June 2023, Cramer has been serving as president of the Max Planck Society.

Achievements

Cramer conducts basic research as the head of the Department of Molecular Biology at the Max Planck Institute in Göttingen. He also works as a science manager and an honorary professor at the University of Göttingen. During his postdoctoral research with Roger Kornberg, Cramer determined the atomic, three-dimensional structure of RNA polymerase II, one of the biggest enzymes in the cell nucleus. This work played a decisive role when the Nobel Prize in chemistry was awarded to Roger Kornberg in 2006 for studies of the molecular basis of eukaryotic transcription.

Cramer's laboratory investigates the molecular mechanisms and systemic principles of gene transcription in eukaryotic cells. The laboratory uses integrated structural biology methods, including X-ray crystallography, cryo-electron microscopy, and biochemical tools. The Cramer laboratory also uses functional genomics and computational biology approaches to study the principles of transcription in living cells.

Cramer's group created the first molecular movie of transcription initiation and elongation. Moreover, Patrick Cramer developed methods to analyze fundamental aspects of RNA metabolism in cells by integrating aspects of both molecular and systems biology. His long-term goal is to understand the expression and the regulation of the genome. The laboratory thus pioneers an approach that combines structural and genome-wide methods and may be referred to as molecular systems biology.

In April 2020, Cramer's team at the Max Planck Institute of Biophysical Chemistry created the first "3D structure of the corona polymerase" for the COVID-19 virus. Their model will allow researchers "to investigate how antiviral drugs such as remdesivir – which blocks the polymerase – work, and to search for new inhibitory substances."

Cramer also commits himself to the further development of life sciences in Germany and Europe. He was one of the founders of the national cluster of excellence "Center for Integrated Protein Science (CIPSM)" and initiated the construction of the new research building, the "Munich Research Center for Molecular Biosystems (BioSysM)".

In addition, Cramer was one of the members of the scientific and technical advisory board of the Bavarian state government and worked on bioethics within the institute TTN.

Other activities

Corporate boards

Non-profit organizations

Publications

Original research articles (selection)

Review articles (selection)

Other publications (selection)

  • Aufbruch in die molekulare Systembiology. - Essay for the anniversary edition "20 Jahre Laborjournal", Published in Laborjournal on 11 July 2014.

  • Entwicklungen in der Biomedizin: Genom-Sequenzierung in Diagnose, Prävention und Therape; Systembiologie und Medizin. In: T. Rendtorff (Hrsg.): Zukunft der biomedizinischen Wissenschaften. Nomos, 2013, .

  • O. Primavesi, P. Cramer, R. Hickel, T. O. Höllmann; W. Schön: Lob der Promotion. Published in Frankfurter Allgemeine Zeitung on 19 July 2013.

  • J. Hacker, T. Rendtorff, P. Cramer, M. Hallek, K. Hilpert, C. Kupatt, M. Lohse, A. Müller, U Schroth, F. Voigt, M. Zichy. Biomedizinische Eingriffe am Menschen – Ein Stufenmodell zur ethischen Bewertung von Gen- und Zelltherapie. Water de Gruyter, Berlin. (2009).

Awards and honours (selection)

References